Literature DB >> 18540916

Differential neural response to alcohol priming and alcohol taste cues is associated with DRD4 VNTR and OPRM1 genotypes.

Francesca M Filbey1, Lara Ray, Andrew Smolen, Eric D Claus, Amy Audette, Kent E Hutchison.   

Abstract

BACKGROUND: Studies suggest that polymorphisms in the D4 dopamine receptor (DRD4) and opioid receptor, mu 1 (OPRM1) genes are involved in differential response to the effects of alcohol and to alcohol cues. However, to date, the mechanisms that underlie these differences remain largely unknown.
METHODS: Using functional magnetic resonance imaging, hemodynamic response in mesocorticolimbic structures after exposure to alcohol tastes was contrasted with a control taste and compared between DRD4 variable number of tandem repeats (VNTR) genotypes and OPRM1 A118G genotypes. Additionally, the effects of a priming dose of alcohol on this response were examined.
RESULTS: The results indicated that DRD4 VNTR >7 repeat individuals (DRD4.L) had significantly greater response to alcohol cues in the orbitofrontal cortex, anterior cingulate gyrus, and striatum compared with individuals with <7 repeats (DRD4.S) prior to a priming dose of alcohol (p < 0.05), but not after a priming dose. In the OPRM1 comparisons, results showed that individuals with at least 1 copy of the OPRM1 + 118 G allele had greater hemodynamic response in mesocorticolimbic areas both before and after priming compared with those who were homozygous for the OPRM1 + 118 A allele. For the DRD4.L and OPRM1 + 118 G groups, brain response in the striatum was highly correlated with measures of alcohol use and behavior such that greater activity corresponded with greater frequency and quantity of alcohol use.
CONCLUSIONS: The DRD4 VNTR and OPRM1 A118G polymorphisms are associated with functional neural changes in mesocorticolimbic structures after exposure to alcohol cues. This provides evidence for the contributions of the DRD4 and OPRM1 genes in modulating neural activity in structures that are involved in the motivation to drink.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18540916      PMCID: PMC2856650          DOI: 10.1111/j.1530-0277.2008.00692.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  45 in total

1.  Genetic and environmental influences on substance initiation, use, and problem use in adolescents.

Authors:  Soo Hyun Rhee; John K Hewitt; Susan E Young; Robin P Corley; Thomas J Crowley; Michael C Stallings
Journal:  Arch Gen Psychiatry       Date:  2003-12

2.  Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G.

Authors:  Ying Zhang; Danxin Wang; Andrew D Johnson; Audrey C Papp; Wolfgang Sadée
Journal:  J Biol Chem       Date:  2005-07-26       Impact factor: 5.157

3.  Reducing susceptibility artifacts in fMRI using volume-selective z-shim compensation.

Authors:  Yiping P Du; Manish Dalwani; Korey Wylie; Eric Claus; Jason R Tregellas
Journal:  Magn Reson Med       Date:  2007-02       Impact factor: 4.668

4.  DRD4 VNTR polymorphism is associated with transient fMRI-BOLD responses to smoking cues.

Authors:  F Joseph McClernon; Kent E Hutchison; Jed E Rose; Rachel V Kozink
Journal:  Psychopharmacology (Berl)       Date:  2007-07-05       Impact factor: 4.530

Review 5.  Review of neurotransmitters and their role in alcoholism treatment.

Authors:  C K Erickson
Journal:  Alcohol Alcohol       Date:  1996-03       Impact factor: 2.826

6.  Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study.

Authors:  Lara A Ray; Kent E Hutchison
Journal:  Arch Gen Psychiatry       Date:  2007-09

7.  A twin-family study of alcoholism in women.

Authors:  K S Kendler; M C Neale; A C Heath; R C Kessler; L J Eaves
Journal:  Am J Psychiatry       Date:  1994-05       Impact factor: 18.112

8.  Olanzapine reduces craving for alcohol: a DRD4 VNTR polymorphism by pharmacotherapy interaction.

Authors:  Kent E Hutchison; Angela Wooden; Robert M Swift; Andrew Smolen; John McGeary; Lawrence Adler; Lyndee Paris
Journal:  Neuropsychopharmacology       Date:  2003-10       Impact factor: 7.853

9.  Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction.

Authors:  C Bond; K S LaForge; M Tian; D Melia; S Zhang; L Borg; J Gong; J Schluger; J A Strong; S M Leal; J A Tischfield; M J Kreek; L Yu
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

10.  The incentive salience of alcohol: translating the effects of genetic variant in CNR1.

Authors:  Kent E Hutchison; Heather Haughey; Michelle Niculescu; Joe Schacht; Alan Kaiser; Jerry Stitzel; William J Horton; Francesca Filbey
Journal:  Arch Gen Psychiatry       Date:  2008-07
View more
  83 in total

1.  OPRM1 and diagnosis-related posttraumatic stress disorder in binge-drinking patients living with HIV.

Authors:  Nicole R Nugent; Michelle A Lally; Larry Brown; Valerie S Knopik; John E McGeary
Journal:  AIDS Behav       Date:  2012-11

2.  Association of genetic copy number variations at 11 q14.2 with brain regional volume differences in an alcohol use disorder population.

Authors:  David Boutte; Vince D Calhoun; Jiayu Chen; Amithrupa Sabbineni; Kent Hutchison; Jingyu Liu
Journal:  Alcohol       Date:  2012-06-23       Impact factor: 2.405

Review 3.  Human laboratory paradigms in alcohol research.

Authors:  Jennifer G Plebani; Lara A Ray; Meghan E Morean; William R Corbin; James MacKillop; Michael Amlung; Andrea C King
Journal:  Alcohol Clin Exp Res       Date:  2012-02-06       Impact factor: 3.455

4.  Effects of nicotine deprivation and replacement on BOLD-fMRI response to smoking cues as a function of DRD4 VNTR genotype.

Authors:  Xiaomeng Xu; Uraina S Clark; Sean P David; Richard C Mulligan; Valerie S Knopik; John McGeary; James MacKillop; Jeanne McCaffery; Raymond S Niaura; Lawrence H Sweet
Journal:  Nicotine Tob Res       Date:  2014-03-22       Impact factor: 4.244

5.  Predictors of Naltrexone Response in a Randomized Trial: Reward-Related Brain Activation, OPRM1 Genotype, and Smoking Status.

Authors:  Joseph P Schacht; Patrick K Randall; Patricia K Latham; Konstantin E Voronin; Sarah W Book; Hugh Myrick; Raymond F Anton
Journal:  Neuropsychopharmacology       Date:  2017-04-14       Impact factor: 7.853

6.  Interacting effects of naltrexone and OPRM1 and DAT1 variation on the neural response to alcohol cues.

Authors:  Joseph P Schacht; Raymond F Anton; Konstantin E Voronin; Patrick K Randall; Xingbao Li; Scott Henderson; Hugh Myrick
Journal:  Neuropsychopharmacology       Date:  2012-10-03       Impact factor: 7.853

7.  Genetic variation in the alpha synuclein gene (SNCA) is associated with BOLD response to alcohol cues.

Authors:  Claire E Wilcox; Eric D Claus; Sara K Blaine; Marilee Morgan; Kent E Hutchison
Journal:  J Stud Alcohol Drugs       Date:  2013-03       Impact factor: 2.582

8.  Real-time assessment of alcohol craving and naltrexone treatment responsiveness in a randomized clinical trial.

Authors:  Robert Miranda; Hayley Treloar Padovano; Joshua C Gray; Stephanie E Wemm; Alexander Blanchard
Journal:  Addict Behav       Date:  2018-01-10       Impact factor: 3.913

9.  Family history of alcoholism mediates the frontal response to alcoholic drink odors and alcohol in at-risk drinkers.

Authors:  David A Kareken; Veronique Bragulat; Mario Dzemidzic; Cari Cox; Thomas Talavage; Dena Davidson; Sean J O'Connor
Journal:  Neuroimage       Date:  2010-01-08       Impact factor: 6.556

10.  Individual and additive effects of the CNR1 and FAAH genes on brain response to marijuana cues.

Authors:  Francesca M Filbey; Joseph P Schacht; Ursula S Myers; Robert S Chavez; Kent E Hutchison
Journal:  Neuropsychopharmacology       Date:  2009-12-09       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.